Search research articles
Contact Us
Filters
Showing results (31-40 of 76) with videos related to
Page
of 8
Sort By:
Targeted Oncology
|
February 18, 2021
BRAFV600E Mutations Arising from a Left-Side Primary in Metastatic Colorectal Cancer: Are They a Distinct Subset?
Vanessa Wong, Margaret Lee, Rachel Wong, et al.
Cancer Medicine
|
October 25, 2022
Clustering on longitudinal quality-of-life measurements using growth mixture models for clinical prognosis: Implementation on CCTG/AGITG CO.20 trial
Jiahui Zhang, Weili Kong, Pingzhao Hu, et al.
Expert Review of Anticancer Therapy
|
March 24, 2020
Management of early-stage gastro-esophageal cancers: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty
Amitesh C Roy, Jeremy Shapiro, Matt Burge, et al.
Expert Review of Anticancer Therapy
|
July 19, 2018
Targeted therapy for metastatic colorectal cancer
Timothy J Price, Monica Tang, Peter Gibbs, et al.
Expert Review of Anticancer Therapy
|
February 27, 2018
Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis
Monica Tang, Timothy Jay Price, Jeremy Shapiro, et al.
Journal of Surgical Education
|
April 15, 2025
From Wilderness to the Bedside: Creating Adventurous and Mindful Physicians Entering Residency (CAMPER) by Residents for Residents to Foster Belongingness
Alec Bernard, Emily L Vogt, Kathryn Flaharty, et al.
International Journal of Cancer
|
March 17, 2021
Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease setting
Louise Kostos, Wei Hong, Belinda Lee, et al.
Clinical Colorectal Cancer
|
January 25, 2016
Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative Intent
Shu Fen Wong, Hui Li Wong, Kathryn M Field, et al.
Clinical Colorectal Cancer
|
May 24, 2025
Exploring Real-World Outcomes of First Line EGFR Inhibitor Use, Cetuximab Versus Panitumumab, in Patients with Left-Sided, RAS Wild-Type, Metastatic Colorectal Cancer
Jane McKenzie, Vanessa Wong, Shehara Mendis, et al.
Targeted Oncology
|
March 15, 2022
The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours
Tiffany Foo, David Goldstein, Eva Segelov, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 76) with videos related to
Sort By:
Page
of 8
Targeted Oncology
|
February 18, 2021
BRAFV600E Mutations Arising from a Left-Side Primary in Metastatic Colorectal Cancer: Are They a Distinct Subset?
Vanessa Wong, Margaret Lee, Rachel Wong, et al.
Cancer Medicine
|
October 25, 2022
Clustering on longitudinal quality-of-life measurements using growth mixture models for clinical prognosis: Implementation on CCTG/AGITG CO.20 trial
Jiahui Zhang, Weili Kong, Pingzhao Hu, et al.
Expert Review of Anticancer Therapy
|
March 24, 2020
Management of early-stage gastro-esophageal cancers: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty
Amitesh C Roy, Jeremy Shapiro, Matt Burge, et al.
Expert Review of Anticancer Therapy
|
July 19, 2018
Targeted therapy for metastatic colorectal cancer
Timothy J Price, Monica Tang, Peter Gibbs, et al.
Expert Review of Anticancer Therapy
|
February 27, 2018
Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis
Monica Tang, Timothy Jay Price, Jeremy Shapiro, et al.
Journal of Surgical Education
|
April 15, 2025
From Wilderness to the Bedside: Creating Adventurous and Mindful Physicians Entering Residency (CAMPER) by Residents for Residents to Foster Belongingness
Alec Bernard, Emily L Vogt, Kathryn Flaharty, et al.
International Journal of Cancer
|
March 17, 2021
Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease setting
Louise Kostos, Wei Hong, Belinda Lee, et al.
Clinical Colorectal Cancer
|
January 25, 2016
Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative Intent
Shu Fen Wong, Hui Li Wong, Kathryn M Field, et al.
Clinical Colorectal Cancer
|
May 24, 2025
Exploring Real-World Outcomes of First Line EGFR Inhibitor Use, Cetuximab Versus Panitumumab, in Patients with Left-Sided, RAS Wild-Type, Metastatic Colorectal Cancer
Jane McKenzie, Vanessa Wong, Shehara Mendis, et al.
Targeted Oncology
|
March 15, 2022
The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours
Tiffany Foo, David Goldstein, Eva Segelov, et al.
Page
of 8